CD44 and lung adenocarcinoma: Additionally, immunocytochemical investigation of the well-established lung adenocarcinoma cell line LXF-289 revealed no expression for CD133 and Nestin and lower expression of CD44, underpinning the presence of a CSC phenotype in the here-presented BKZ cell populations.